LifeVantageLFVN
LFVN
About: Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Employees: 222
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
350% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 8
94% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 16
63% more call options, than puts
Call options by funds: $379K | Put options by funds: $233K
36% more funds holding
Funds holding: 77 [Q4 2024] → 105 (+28) [Q1 2025]
29% more capital invested
Capital invested by funds: $72.9M [Q4 2024] → $93.9M (+$21M) [Q1 2025]
18.15% more ownership
Funds ownership: 33.2% [Q4 2024] → 51.34% (+18.15%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for LFVN.
Financial journalist opinion
Based on 4 articles about LFVN published over the past 30 days
Neutral
GlobeNewsWire
6 days ago
LifeVantage To Open Iceland Market
SALT LAKE CITY, July 24, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced its upcoming launch into Iceland expected in September. This marks the company's continued partnership with its field leadership on international expansion and reinforces its commitment to delivering science-backed wellness solutions to consumers around the world.
Neutral
GlobeNewsWire
1 week ago
LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡
Expanded U.S.-clinical research study shows strong results including increased fat loss, improved cravings control, and healthier body composition*‡ Expanded U.S.-clinical research study shows strong results including increased fat loss, improved cravings control, and healthier body composition*‡
Positive
Seeking Alpha
1 week ago
The LifeVantage Advantage: High Retention, High Returns
LifeVantage leads in nutrigenomics, focusing on how nutrition impacts gene expression for optimal health. LifeVantage projections indicate a strong 26.6% EPS CAGR through 2027, driven by high-margin products, cost controls, and a shift toward long-term wellness-focused consultant strategies. The MindBody GLP-1 System now accounts for most of LFVN's growth, with 85% of new users on monthly subscriptions, creating a reliable and recurring revenue stream.
Neutral
GlobeNewsWire
2 weeks ago
LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campaign and Incentive to Drive Global Growth
SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, held its global Activate 2025 virtual event on Saturday, July 12. The event, supported by Consultant-hosted watch parties and local in-person gatherings, provided a dynamic platform to inspire Consultant business engagement and growth. Activate 2025 also celebrated innovation, reinforcing LifeVantage's ongoing commitment to evolving the direct selling model in today's fast-paced market.
Neutral
Seeking Alpha
2 months ago
LifeVantage Corporation (LFVN) Q3 2025 Earnings Call Transcript
LifeVantage Corporation (NASDAQ:LFVN ) Q3 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Reed Anderson - Managing Director-ICR Steve Fife - President and Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by.
Neutral
GlobeNewsWire
2 months ago
LifeVantage Declares Quarterly Dividend
SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid June 13, 2025 to all stockholders of record at the close of business on May 30, 2025. This represents an increase in the dividend amount by 12.5% over the previous quarter.
Neutral
GlobeNewsWire
2 months ago
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025
SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025. Third Quarter Fiscal 2025 Summary*: Revenue was $58.4 million, an increase of 21.1% from the prior year period.
Positive
Seeking Alpha
2 months ago
LifeVantage: Activation Of Shareholder Value
LifeVantage (LFVN) is a mispriced opportunity with potential for >15% IRR, driven by its new GLP-1 product suite and turnaround signals. LFVN's valuation is attractive at ~6x EV/EBITDA and a Fwd PEG of 0.15x, trading below sector median despite strong growth potential. The company's revamped business model and compensation package have increased active accounts by 25%, indicating early signs of success turnaround and enhanced sales outreach which the market is not reacting.
Neutral
GlobeNewsWire
3 months ago
Global Convention 2025 Empowers Consultants to ‘Go Further' with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth
SALT LAKE CITY, April 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion of their annual Global Convention, held April 24-26, 2025, in Salt Lake City, Utah. Thousands of independent LifeVantage Consultants from around the world gathered at the Salt Palace Convention Center to participate in the multi-day event.
Neutral
GlobeNewsWire
3 months ago
LifeVantage to Announce Third Quarter Fiscal Year 2025 Results on May 6, 2025
SALT LAKE CITY, April 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2025, after the stock market closes on Tuesday, May 6, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Charts implemented using Lightweight Charts™